Babatunde Olubajo, PhD, MPH

Principal Health Research Analyst
CDC

Disclosure(s): No financial relationships to disclose

Poster(s):

• 427 - Trends in Hospital-onset Escherichia coli Infections Resistant to Fluoroquinolones and Extended-spectrum Cephalosporins, 2012-2020
  Thursday, October 20, 2022

  12:15 PM – 1:30 PM US ET

• 1864 - Trends in Staphylococcus aureus Bacteremia Rates among U.S. Acute Care Hospitals, January 2017- June 2021
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET

• 2005 - Direct Hospitalization Costs Associated with Resistant and Susceptible Salmonella and Shigella Infections in the United States — 2012–2019
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET

• 2049 - National Trends in Infections caused by Pseudomonas aeruginosa and Carbapenem Resistant Pseudomonas aeruginosa, 2017 – 2020
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET

• 2050 - Proportion of hospital-onset infections expressing antibiotic resistant (AR) phenotypes in US Hospitals, 2018 – 2020
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET

• 2056 - Trends in the Rates of Multidrug-resistant Bacteria Commonly Associated with Healthcare in U.S. Acute Care Hospitals, 2019-June 2021
  Saturday, October 22, 2022

  12:15 PM – 1:30 PM US ET